Chris Torrance

Non-Executive Director


Dr Chris Torrance is a scientist and entrepreneur, and is CEO of PhoreMost, an early stage drug discovery company he founded in 2015.

In 2007 Chris founded Horizon Discovery to translate advances in human genome editing into a range of commercial products and services. By 2014, when it listed on the London Stock Exchange, Horizon had become the fastest growing Biotech company in the UK. Previously, Chris was Head of Oncology and Biology at the UK Biotechnology company Vernalis PLC, where he was responsible for progressing several novel kinase oncology programs.